TNPO1 and amyotrophic lateral sclerosis: These importins could be therapeutically exploited to antagonize aberrant aggregation of ALS-associated variants of FUS which lack the C-terminal PY-NLS or weaken the TNPO1-PY-NLS interaction [7, 275].